Xytis Inc.

United States of America

Back to Profile

1-2 of 2 for Xytis Inc. Sort by
Query
Aggregations
IPC Class
A61P 25/00 - Drugs for disorders of the nervous system 2
C07D 265/14 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring 2
A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2 1
A61K 31/535 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines 1
Found results for  patents

1.

ENANTIOMERICALLY PURE R-ETIFOXINE, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS OF THEIR USE

      
Application Number US2007006958
Publication Number 2007/109288
Status In Force
Filing Date 2007-03-20
Publication Date 2007-09-27
Owner XYTIS INC. (USA)
Inventor
  • Putman, David, G.
  • Hogenkamp, Derk, J.
  • Dasse, Olivier, A.
  • Whittemore, Edward, R.
  • Jensen, Mark, S.

Abstract

Enantiomerically pure R-etifoxine and pharmaceutically acceptable salts, solvates, hydrates or prodrugs thereof are provided. Also provided are pharmaceutical compositions comprising the compounds and methods of treating disorders associated with central nervous system using the compounds and pharmaceutical compositions.

IPC Classes  ?

  • C07D 265/14 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61P 25/00 - Drugs for disorders of the nervous system

2.

ENANTIOMERICALLY PURE S-ETIFOXINE, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS OF THEIR USE

      
Application Number US2007006959
Publication Number 2007/109289
Status In Force
Filing Date 2007-03-20
Publication Date 2007-09-27
Owner XYTIS INC. (USA)
Inventor
  • Putman, David, G.
  • Hogenkamp, Derk, J.
  • Dasse, Olivier, A.
  • Whittemore, Edward, R.
  • Jensen, Mark, S.

Abstract

Enantiomerically pure S-etifoxine and pharmaceutically acceptable salts, solvates, hydrates or prodrugs thereof are provided. Also provided are pharmaceutical compositions comprising the compounds and methods of treating disorders associated with central nervous system using the compounds and pharmaceutical compositions.

IPC Classes  ?

  • C07D 265/14 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
  • A61K 31/535 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61P 25/00 - Drugs for disorders of the nervous system